2,405 Shares in HCA Healthcare, Inc. $HCA Bought by Prana Capital Management LP

Prana Capital Management LP bought a new stake in HCA Healthcare, Inc. (NYSE:HCA) in the third quarter, HoldingsChannel reports. The fund bought 2,405 shares of the company’s stock, valued at approximately $1,025,000.

Other large investors also recently bought and sold shares of the company. Capital World Investors boosted its stake in shares of HCA Healthcare by 3.8% in the third quarter. Capital World Investors now owns 4,959,336 shares of the company’s stock valued at $2,113,662,000 after purchasing an additional 179,443 shares during the period. Norges Bank purchased a new stake in shares of HCA Healthcare during the second quarter worth about $1,152,408,000. Arrowstreet Capital Limited Partnership increased its holdings in HCA Healthcare by 1.8% during the 3rd quarter. Arrowstreet Capital Limited Partnership now owns 2,065,225 shares of the company’s stock worth $880,199,000 after purchasing an additional 36,414 shares during the last quarter. Viking Global Investors LP grew its position in shares of HCA Healthcare by 58.5% during the second quarter. Viking Global Investors LP now owns 1,872,133 shares of the company’s stock worth $717,214,000 after buying an additional 690,773 shares in the last quarter. Finally, Legal & General Group Plc raised its holdings in HCA Healthcare by 0.8% in the third quarter. Legal & General Group Plc now owns 1,124,511 shares of the company’s stock valued at $479,267,000 after acquiring an additional 8,478 shares in the last quarter. Institutional investors and hedge funds own 62.73% of the company’s stock.

Insider Transactions at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 1,500 shares of the company’s stock in a transaction on Tuesday, February 3rd. The shares were sold at an average price of $498.09, for a total value of $747,135.00. Following the completion of the sale, the executive vice president directly owned 30,003 shares in the company, valued at approximately $14,944,194.27. This represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this link. Also, EVP Michael R. Mcalevey sold 1,694 shares of the business’s stock in a transaction that occurred on Wednesday, February 18th. The stock was sold at an average price of $533.37, for a total value of $903,528.78. Following the completion of the sale, the executive vice president owned 8,853 shares of the company’s stock, valued at approximately $4,721,924.61. This trade represents a 16.06% decrease in their ownership of the stock. The disclosure for this sale is available in the SEC filing. Over the last three months, insiders have sold 15,214 shares of company stock worth $7,797,595. 1.30% of the stock is owned by company insiders.

HCA Healthcare Price Performance

NYSE HCA opened at $510.34 on Wednesday. The company’s 50 day simple moving average is $508.54 and its 200 day simple moving average is $472.06. The firm has a market capitalization of $114.10 billion, a PE ratio of 17.98, a P/E/G ratio of 1.61 and a beta of 1.34. HCA Healthcare, Inc. has a 12 month low of $314.43 and a 12 month high of $556.52.

HCA Healthcare (NYSE:HCA) last issued its quarterly earnings results on Tuesday, January 27th. The company reported $8.01 EPS for the quarter, topping the consensus estimate of $7.37 by $0.64. HCA Healthcare had a net margin of 8.97% and a negative return on equity of 409.11%. The firm had revenue of $19.51 billion for the quarter, compared to analysts’ expectations of $19.67 billion. During the same period in the previous year, the business earned $6.22 earnings per share. HCA Healthcare’s revenue for the quarter was up 6.7% compared to the same quarter last year. HCA Healthcare has set its FY 2026 guidance at 29.100-31.500 EPS. Sell-side analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 31st. Investors of record on Tuesday, March 17th will be given a dividend of $0.78 per share. The ex-dividend date of this dividend is Tuesday, March 17th. This is a boost from HCA Healthcare’s previous quarterly dividend of $0.72. This represents a $3.12 dividend on an annualized basis and a yield of 0.6%. HCA Healthcare’s payout ratio is presently 10.15%.

Analyst Ratings Changes

HCA has been the topic of a number of recent analyst reports. TD Cowen upped their target price on shares of HCA Healthcare from $529.00 to $561.00 and gave the company a “buy” rating in a research note on Tuesday, March 10th. Wells Fargo & Company upped their price objective on HCA Healthcare from $452.00 to $481.00 and gave the company an “equal weight” rating in a research note on Friday, January 30th. Leerink Partners raised their price objective on HCA Healthcare from $507.00 to $573.00 and gave the stock an “outperform” rating in a research note on Wednesday, January 28th. Wall Street Zen lowered shares of HCA Healthcare from a “strong-buy” rating to a “buy” rating in a report on Saturday, February 14th. Finally, Jefferies Financial Group lifted their target price on HCA Healthcare from $535.00 to $590.00 and gave the company a “buy” rating in a research note on Wednesday, January 28th. Sixteen investment analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has issued a Sell rating to the company’s stock. According to MarketBeat.com, HCA Healthcare currently has a consensus rating of “Moderate Buy” and a consensus target price of $537.73.

HCA Healthcare Profile

HCA Healthcare is a for‑profit operator of healthcare facilities headquartered in Nashville, Tennessee. Founded in 1968, the company owns and operates a network of hospitals and related healthcare facilities and has grown through organic expansion and acquisitions to become a large provider of inpatient and outpatient services.

The company’s core activities include the operation of acute care hospitals, freestanding surgical and emergency centers, and outpatient clinics. HCA’s services encompass inpatient care, surgical services, emergency medicine, diagnostic imaging and laboratory testing, and various outpatient and ambulatory care offerings.